| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Olaf Hoffmann,1,
Miriam Schickhaus,1
Dorette Freyer,1
Emilie Dagand,1
Daniela Bermpohl,1
Tim J. Mitchell,4
Ingo Bechmann,2 and
Joerg R. Weber1,2
Departments of Neurology,1 Cell Biology and Neurobiology, Charité Universitaetsmedizin Berlin, Berlin, Germany,2 Division of Neurology, Department of Internal Medicine, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates,3 Division of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom4
Received 7 January 2007/ Returned for modification 21 February 2007/ Accepted 1 June 2007
Bacterial toxins such as pneumolysin are key mediators of cytotoxicity in infections. Pneumolysin is a pore-forming toxin released by Streptococcus pneumoniae, the major cause of bacterial meningitis. We found that pneumolysin is the pneumococcal factor that accounts for the cell death pathways induced by live bacteria in primary neurons. The pore-forming activity of pneumolysin is essential for the induction of mitochondrial damage and apoptosis. Pneumolysin colocalized with mitochondrial membranes, altered the mitochondrial membrane potential, and caused the release of apoptosis-inducing factor and cell death. Pneumolysin induced neuronal apoptosis without activating caspase-1, -3, or -8. Wild-type pneumococci also induced apoptosis without activation of caspase-3, whereas pneumolysin-negative pneumococci activated caspase-3 through the release of bacterial hydrogen peroxide. Pneumolysin caused upregulation of X-chromosome-linked inhibitor of apoptosis protein and inhibited staurosporine-induced caspase activation, suggesting the presence of actively suppressive mechanisms on caspases. In conclusion, our results indicate additional functions of pneumolysin as a mitochondrial toxin and as a determinant of caspase-independent apoptosis. Considering this, blocking of pneumolysin may be a promising cytoprotective strategy in pneumococcal meningitis and other infections.
Published ahead of print on 11 June 2007.
J.S.B. and O.H. contributed equally to this work.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|